For this reason, we could not use the Gi method for reducing GFAP+ cell function and instead opted for the astroglial depletion approach, which more closely models the GFAP+ astroglial density reductions associated with MDD pathology [7, 8, 17, 18, 28]. This evidence concerns the gene GNAI1 and major depressive disorder.